Discrete Half-Logistic Distribution: Statistical Properties, Estimation, and Application

This article presented a novel discrete distribution with one parameter derived by the discretization approach and called the discrete half-logistic distribution. Its probability mass function and hazard function have different shapes. A variety of its statistical properties, including moments, probability generating function, incomplete moments, and order statistics, were determined mathematically. Maximum likelihood, moments, and proportion estimation methods were used to estimate its parameter. A simulation study conducts to check the various estimating method’s performance. By using a real data set, its flexibility is assessed. Lastly, it can model count data sets in a way that is compared with other distributions that are already in the scientific literature

ANALYSIS OF EGYPTIAN AGRICULTURAL FOREIGN TRADE WITH THE COUNTRIES OF THE EURO - ASIAN UNION

The study aims at identifying the analysis of the Egyptian agricultural foreign trade with the countries of the Euro-Asian Union. The  study problem , its objectives and the research method Where identified in the study. Where , there is a lack of information on the expected results or the role that the proposed free trade agreement between Egypt and the Euro-Asian Union could play and the requirements for maximizing the positive results and minimizing the negative consequences if this agreement is signed. Therefore, the research aims to identify the positive and negative results on the Egyptian economy under the proposed agreement, which contributes to reducing the negatives and supporting the positive factors to achieve effective decision-making. The study included four chapters. First, identifying the stages of economic integration. The second chapter was studying the economic interrelationships between the Russian Federation, Egypt, Belarus, Armenia and Kazakhstan, and the third chapter was the identification of commodity trade relations between Egypt and Eurasian countries during the period 2001-2017 through exports and imports  between Egypt and  the countries of the Euro-Asian Union The most important trading partner of Egypt among these countries is the Russian Federation, where the value of trade exchange between the two countries in 2017 to more than 4 billion dollars, including 3.6 billion imports to Egypt and 0.5 billion exports from Egypt to Russia, The fourth chapter was the use of trade indicators to reveal trade opportunities with the countries of the Euro-Asian Customs Union. Three indicators were used: 1- Conditions of trade, 2- Agricultural trade compatibility, 3- Price competitiveness, The tendency of the terms of exchange for Egypt in many commodities of vegetables and fruits in the studied markets and the most important Russian market and  it shows  the agricultural trade compatibility of these commodities and the advantage of some Egyptian commodities such as oranges, potatoes and grapes have a significant competitive advantage in the Russian market with great importance. The research included several recommendations, including the promotion of intraagricultural trade between Egypt and the EuroAsian countries through preferential agreements, especially with Russia, Armenia and Kazakhstan

Novel Human Podocyte Cell Model Carrying G2/G2 APOL1 High-Risk Genotype

Contains fulltext : 237490.pdf (Publisher’s version ) (Open Access

ERP Conceptual Ecology

The technological evolution of recent years has made that information systems frequently adapt to the market realities to fulfill the improvements of the company’s organizational processes. In this context, new paradigms, approaches, and concepts were disseminated through the new realities of information systems. This study aims to verify how ERP (Enterprise Resource Planning) has been related to other information systems within its ecosystem. For this purpose, we have reviewed the literature based on 650 publications whose central theme was the ERP. The data were treated through a graphical analysis, inspired by SNA (Social Network Analysis), represented by related ERP concepts. The study results, determine the connection degree between the concepts that emerged with the technological evolution and the ERP, thus representing the ERP interoperability tendencies, over the last years. The study concludes that ERPs have been improving and substantially increasing the conditions of nteroperability with other information systems and with new organizational concepts that have emerged through the technological availability. This fact led to a better organizational process’s adoption and more organizational performance.info:eu-repo/semantics/publishedVersio

Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000-2021: a systematic analysis from the Global Burden of Disease Study 2021

BACKGROUND: Previous global analyses, with known underdiagnosis and single cause per death attribution systems, provide only a small insight into the suspected high population health effect of sickle cell disease. Completed as part of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021, this study delivers a comprehensive global assessment of prevalence of sickle cell disease and mortality burden by age and sex for 204 countries and territories from 2000 to 2021. METHODS: We estimated cause-specific sickle cell disease mortality using standardised GBD approaches, in which each death is assigned to a single underlying cause, to estimate mortality rates from the International Classification of Diseases (ICD)-coded vital registration, surveillance, and verbal autopsy data. In parallel, our goal was to estimate a more accurate account of sickle cell disease health burden using four types of epidemiological data on sickle cell disease: birth incidence, age-specific prevalence, with-condition mortality (total deaths), and excess mortality (excess deaths). Systematic reviews, supplemented with ICD-coded hospital discharge and insurance claims data, informed this modelling approach. We employed DisMod-MR 2.1 to triangulate between these measures-borrowing strength from predictive covariates and across age, time, and geography-and generated internally consistent estimates of incidence, prevalence, and mortality for three distinct genotypes of sickle cell disease: homozygous sickle cell disease and severe sickle cell β-thalassaemia, sickle-haemoglobin C disease, and mild sickle cell β-thalassaemia. Summing the three models yielded final estimates of incidence at birth, prevalence by age and sex, and total sickle cell disease mortality, the latter of which was compared directly against cause-specific mortality estimates to evaluate differences in mortality burden assessment and implications for the Sustainable Development Goals (SDGs). FINDINGS: Between 2000 and 2021, national incidence rates of sickle cell disease were relatively stable, but total births of babies with sickle cell disease increased globally by 13·7% (95% uncertainty interval 11·1-16·5), to 515 000 (425 000-614 000), primarily due to population growth in the Caribbean and western and central sub-Saharan Africa. The number of people living with sickle cell disease globally increased by 41·4% (38·3-44·9), from 5·46 million (4·62-6·45) in 2000 to 7·74 million (6·51-9·2) in 2021. We estimated 34 400 (25 000-45 200) cause-specific all-age deaths globally in 2021, but total sickle cell disease mortality burden was nearly 11-times higher at 376 000 (303 000-467 000). In children younger than 5 years, there were 81 100 (58 800-108 000) deaths, ranking total sickle cell disease mortality as 12th (compared to 40th for cause-specific sickle cell disease mortality) across all causes estimated by the GBD in 2021. INTERPRETATION: Our findings show a strikingly high contribution of sickle cell disease to all-cause mortality that is not apparent when each death is assigned to only a single cause. Sickle cell disease mortality burden is highest in children, especially in countries with the greatest under-5 mortality rates. Without comprehensive strategies to address morbidity and mortality associated with sickle cell disease, attainment of SDG 3.1, 3.2, and 3.4 is uncertain. Widespread data gaps and correspondingly high uncertainty in the estimates highlight the urgent need for routine and sustained surveillance efforts, further research to assess the contribution of conditions associated with sickle cell disease, and widespread deployment of evidence-based prevention and treatment for those with sickle cell disease. FUNDING: Bill & Melinda Gates Foundation

Zebrafish as a model for kidney function and disease

Kidney disease is a global problem with around three million people diagnosed in the UK alone and the incidence is rising. Research is critical to develop better treatments. Animal models can help to better understand the pathophysiology behind the various kidney diseases and to screen for therapeutic compounds, but the use especially of mammalian models should be minimised in the interest of animal welfare. Zebrafish are increasingly used, as they are genetically tractable and have a basic renal anatomy comparable to mammalian kidneys with glomerular filtration and tubular filtration processing. Here, we discuss how zebrafish have advanced the study of nephrology and the mechanisms underlying kidney disease

Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019

Background Diabetes, particularly type 1 diabetes, at younger ages can be a largely preventable cause of death with the correct health care and services. We aimed to evaluate diabetes mortality and trends at ages younger than 25 years globally using data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019. Methods We used estimates of GBD 2019 to calculate international diabetes mortality at ages younger than 25 years in 1990 and 2019. Data sources for causes of death were obtained from vital registration systems, verbal autopsies, and other surveillance systems for 1990–2019. We estimated death rates for each location using the GBD Cause of Death Ensemble model. We analysed the association of age-standardised death rates per 100 000 population with the Socio-demographic Index (SDI) and a measure of universal health coverage (UHC) and described the variability within SDI quintiles. We present estimates with their 95% uncertainty intervals. Findings In 2019, 16 300 (95% uncertainty interval 14 200 to 18 900) global deaths due to diabetes (type 1 and 2 combined) occurred in people younger than 25 years and 73·7% (68·3 to 77·4) were classified as due to type 1 diabetes. The age-standardised death rate was 0·50 (0·44 to 0·58) per 100 000 population, and 15 900 (97·5%) of these deaths occurred in low to high-middle SDI countries. The rate was 0·13 (0·12 to 0·14) per 100 000 population in the high SDI quintile, 0·60 (0·51 to 0·70) per 100 000 population in the low-middle SDI quintile, and 0·71 (0·60 to 0·86) per 100 000 population in the low SDI quintile. Within SDI quintiles, we observed large variability in rates across countries, in part explained by the extent of UHC (r2=0·62). From 1990 to 2019, age-standardised death rates decreased globally by 17·0% (−28·4 to −2·9) for all diabetes, and by 21·0% (–33·0 to −5·9) when considering only type 1 diabetes. However, the low SDI quintile had the lowest decline for both all diabetes (−13·6% [–28·4 to 3·4]) and for type 1 diabetes (−13·6% [–29·3 to 8·9]). Interpretation Decreasing diabetes mortality at ages younger than 25 years remains an important challenge, especially in low and low-middle SDI countries. Inadequate diagnosis and treatment of diabetes is likely to be major contributor to these early deaths, highlighting the urgent need to provide better access to insulin and basic diabetes education and care. This mortality metric, derived from readily available and frequently updated GBD data, can help to monitor preventable diabetes-related deaths over time globally, aligned with the UN's Sustainable Development Targets, and serve as an indicator of the adequacy of basic diabetes care for type 1 and type 2 diabetes across nations.publishedVersio